Gimv posts EUR 15.0 million profit for the year, giving a net asset value of EUR 40.12 per share
. Topic: Annual report The results for the 2013-2014 financial year cover the period from 1 April 2013 to 31 March 2…
. Topic: Annual report The results for the 2013-2014 financial year cover the period from 1 April 2013 to 31 March 2…
Since its inception in 2007, DG Infra has put itself firmly on the map with 20 investments in pure infrastructure initia…
Gimv and Gimv-managed Biotech Fonds Vlaanderen sold their remaining stake in the Belgian biotech company Ablynx yesterda…
Gimv today announced that 57.2% of the no.20 coupons had been presented in return for 760,994 new ordinary shares, for a…
On 1 July 2013, Fidelity Management and Research LLC ("FMR LLC"), located at 82 Devonshire street, Boston, Massachusetts…
Gimv today held its General Shareholders' Meeting (AGM). 35,36% of the shares were represented (8.473.689 shares). The A…
Gimv and Gimv managed Biotech Fonds Vlaanderen invest in Complix, a biopharmaceutical company focused on the discovery a…
. Topic: Events concerning the stock: dividend payment Subject to approval of today's General Meeting of Shareholder…
The results for the 2012-2013 financial year cover the period from April 2012 to 31 March 2013. Key elements (limited…
. - Rights issue for an amount of up to EUR 20.2m - Subscription price: EUR 0.49 per new share Option representing a d…